LABU is a 3x leveraged ETF designed to magnify the daily performance of the S&P Biotechnology Select Industry Index. Given the inherently extreme volatility of biotech and innovative pharma companies, combined with 3x leverage, the fund exhibits violent boom-and-bust price actions, strictly designed for high-risk speculation.